MyPeptideMatchPeptide Therapy Insights
Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.
Latest Articles
RegulatoryIs O-304 Legal? FDA Status and Regulations Explained (2026)
Explore the legal status of O-304, its FDA classification, compounding regulations, and what patients need to know about this research compound.
RegulatoryIs Pal-AHK Legal? FDA Status and Regulations Explained (2026)
Explore the legal status of Pal-AHK, a research peptide known for tissue regeneration. Understand its FDA classification, compounding legality, and implications for patients.
RegulatoryIs Pal-GHK (Palmitoyl Tripeptide-1) Legal? FDA Status and Regulations Explained (2026)
Explore the legal status of Pal-GHK (Palmitoyl Tripeptide-1), its FDA status, compounding legality, and what patients need to know about this research peptide.
RegulatoryIs Pentapeptide-18 (Leuphasyl) Legal? FDA Status and Regulations Explained (2026)
Explore the legal status of Pentapeptide-18 (Leuphasyl), its FDA classification, compounding regulations, and what this means for patients and researchers.
RegulatoryIs GHK-Cu (Copper Peptide) Legal? FDA Status and Regulations Explained (2026)
Explore the legal status of GHK-Cu (Copper Peptide), its FDA classification, compounding regulations, and what patients need to know in 2026.
RegulatoryIs Tesamorelin Legal? FDA Status and Regulations Explained (2026)
Explore the legal status of Tesamorelin, including its FDA approval, compounding regulations, and what patients need to know about its use.
RegulatoryIs Vialox (Pentapeptide-3V) Legal? FDA Status and Regulations Explained (2026)
Explore the legal status of Vialox (Pentapeptide-3V), its FDA classification, compounding legality, and what patients need to know about this research peptide.
GuidesTirzepatide: 15 Questions Answered by Experts
Get expert answers to the most commonly asked questions about Tirzepatide, a dual GIP/GLP-1 receptor agonist used for weight loss and type 2 diabetes management.
Protocols & StacksGLP-1 Weight Loss Peptide Protocol: Semaglutide & Tirzepatide Dosing Guide (2026)
Explore the GLP-1 Weight Loss Peptide Protocol using Semaglutide and Tirzepatide, including dosing, administration, and expected outcomes.
Stay Up to Date
New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.